BioRestorative Net Debt from 2010 to 2025

BRTX Stock

USD 1.52 0.10 6.17%

BioRestorative Therapies Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2025. Net Debt is the total debt of BioRestorative Therapies minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2010-12-31

Previous Quarter

-2.2 M

Current Value

-1.4 M

Quarterly Volatility

5.9 M

Credit Downgrade

Yuan Drop

Covid

Check BioRestorative Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRestorative Therapies' main balance sheet or income statement drivers, such as Interest Expense of 12.7 K, Selling General Administrative of 7.7 M or Depreciation And Amortization of 178.1 K, as well as many indicators such as Price To Sales Ratio of 54.99, Dividend Yield of 0.0 or PTB Ratio of 0.69. BioRestorative financial statements analysis is a perfect complement when working with BioRestorative Therapies Valuation or Volatility modules.

Check out the analysis of BioRestorative Therapies Correlation against competitors.

For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

Latest BioRestorative Therapies' Net Debt Growth Pattern

Below is the plot of the Net Debt of BioRestorative Therapies over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. BioRestorative Therapies' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioRestorative Therapies' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

BioRestorative Net Debt Regression Statistics

	Arithmetic Mean	965,491
	Coefficient Of Variation	648.63
	Mean Deviation	3,602,541
	Median	2,124,779
	Standard Deviation	6,262,505
	Sample Variance	39.2T
	Range	28.1M
	R-Value	(0.39)
	Mean Square Error	35.7T
	R-Squared	0.15
	Significance	0.14
	Slope	(509,334)
	Total Sum of Squares	588.3T

BioRestorative Net Debt History

	2025	-617.4 K
	2024	-649.9 K
	2023	-722.1 K
	2022	-1.4 M
	2021	-20.4 M
	2020	1.7 M
	2019	7.8 M

Other Fundumenentals of BioRestorative Therapies

Net Debt To E B I T D A

BioRestorative Therapies Net Debt component correlations

	Total Assets	Total Stockholder Equity	Accounts Payable	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Net Debt	Retained Earnings	Long Term Debt	Total Current Assets	Treasury Stock	Short Term Debt	Current Deferred Revenue	Net Tangible Assets	Short Long Term Debt	Net Receivables	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Debt Total	Capital Surpluse
Total Assets		0.97	-0.66	-0.72	0.01	-0.32	0.28	-0.81	-0.82	-0.41	0.97	0.42	-0.63	-0.5	0.95	-0.69	-0.56	0.95	0.95	-0.05	-0.43	-0.43
Total Stockholder Equity	0.97		-0.74	-0.87	0.13	-0.17	0.16	-0.8	-0.71	-0.43	0.92	0.38	-0.75	-0.6	0.92	-0.69	-0.44	0.92	0.93	-0.03	-0.39	-0.39
Accounts Payable	-0.66	-0.74		0.73	-0.2	-0.3	0.29	0.44	0.43	-0.06	-0.61	-0.31	0.56	0.62	-0.62	0.31	0.13	-0.63	-0.67	-0.26	0.31	0.31
Total Liab	-0.72	-0.87	0.73		-0.32	-0.15	0.08	0.64	0.36	0.37	-0.64	-0.25	0.84	0.67	-0.69	0.56	0.13	-0.69	-0.71	-0.02	0.18	0.18
Intangible Assets	0.01	0.13	-0.2	-0.32		0.25	-0.25	0.03	0.36	-0.21	-0.21	-0.1	-0.17	-0.18	-0.2	0.28	0.35	-0.2	-0.2	-0.09	0.08	0.08
Common Stock	-0.32	-0.17	-0.3	-0.15	0.25		-0.65	0.19	0.53	0.61	-0.36	-0.2	-0.14	-0.2	-0.35	0.44	0.54	-0.3	-0.3	0.15	0.2	0.2
Property Plant Equipment	0.28	0.16	0.29	0.08	-0.25	-0.65		-0.12	-0.45	-0.34	0.31	0.26	0.06	0.1	0.31	-0.32	-0.36	0.26	0.21	-0.37	-0.14	-0.14
Net Debt	-0.81	-0.8	0.44	0.64	0.03	0.19	-0.12		0.53	0.33	-0.8	-0.1	0.56	0.34	-0.72	0.59	0.43	-0.82	-0.79	0.01	0.09	0.09
Retained Earnings	-0.82	-0.71	0.43	0.36	0.36	0.53	-0.45	0.53		0.23	-0.87	-0.42	0.45	0.11	-0.86	0.77	0.82	-0.84	-0.86	-0.13	0.4	0.4
Long Term Debt	-0.41	-0.43	-0.06	0.37	-0.21	0.61	-0.34	0.33	0.23		-0.35	-0.22	0.24	0.42	-0.41	0.38	0.13	-0.32	-0.33	0.48	0.21	0.21
Total Current Assets	0.97	0.92	-0.61	-0.64	-0.21	-0.36	0.31	-0.8	-0.87	-0.35		0.43	-0.58	-0.46	0.97	-0.73	-0.62	0.97	0.98	-0.03	-0.43	-0.43
Treasury Stock	0.42	0.38	-0.31	-0.25	-0.1	-0.2	0.26	-0.1	-0.42	-0.22	0.43		-0.32	-0.28	0.53	-0.39	-0.28	0.33	0.4	-0.07	-0.8	-0.8
Short Term Debt	-0.63	-0.75	0.56	0.84	-0.17	-0.14	0.06	0.56	0.45	0.24	-0.58	-0.32		0.35	-0.68	0.76	0.32	-0.61	-0.68	-0.24	0.32	0.32
Current Deferred Revenue	-0.5	-0.6	0.62	0.67	-0.18	-0.2	0.1	0.34	0.11	0.42	-0.46	-0.28	0.35		-0.51	0.07	-0.26	-0.44	-0.46	0.46	0.28	0.28
Net Tangible Assets	0.95	0.92	-0.62	-0.69	-0.2	-0.35	0.31	-0.72	-0.86	-0.41	0.97	0.53	-0.68	-0.51		-0.81	-0.59	0.93	0.97	-0.01	-0.53	-0.53
Short Long Term Debt	-0.69	-0.69	0.31	0.56	0.28	0.44	-0.32	0.59	0.77	0.38	-0.73	-0.39	0.76	0.07	-0.81		0.68	-0.74	-0.8	-0.31	0.38	0.38
Net Receivables	-0.56	-0.44	0.13	0.13	0.35	0.54	-0.36	0.43	0.82	0.13	-0.62	-0.28	0.32	-0.26	-0.59	0.68		-0.6	-0.61	-0.24	0.27	0.27
Net Invested Capital	0.95	0.92	-0.63	-0.69	-0.2	-0.3	0.26	-0.82	-0.84	-0.32	0.97	0.33	-0.61	-0.44	0.93	-0.74	-0.6		0.98	0.06	-0.25	-0.25
Net Working Capital	0.95	0.93	-0.67	-0.71	-0.2	-0.3	0.21	-0.79	-0.86	-0.33	0.98	0.4	-0.68	-0.46	0.97	-0.8	-0.61	0.98		0.12	-0.4	-0.4
Capital Stock	-0.05	-0.03	-0.26	-0.02	-0.09	0.15	-0.37	0.01	-0.13	0.48	-0.03	-0.07	-0.24	0.46	-0.01	-0.31	-0.24	0.06	0.12		0.07	0.07
Long Term Debt Total	-0.43	-0.39	0.31	0.18	0.08	0.2	-0.14	0.09	0.4	0.21	-0.43	-0.8	0.32	0.28	-0.53	0.38	0.27	-0.25	-0.4	0.07		1.0
Capital Surpluse	-0.43	-0.39	0.31	0.18	0.08	0.2	-0.14	0.09	0.4	0.21	-0.43	-0.8	0.32	0.28	-0.53	0.38	0.27	-0.25	-0.4	0.07	1.0

Click cells to compare fundamentals

About BioRestorative Therapies Financial Statements

BioRestorative Therapies investors use historical fundamental indicators, such as BioRestorative Therapies' Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRestorative Therapies. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	-649.9 K	-617.4 K
Net Debt To EBITDA	0.04	0.05

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioRestorative Net Debt from 2010 to 2025

Latest BioRestorative Therapies' Net Debt Growth Pattern

BioRestorative Net Debt Regression Statistics

BioRestorative Net Debt History

Other Fundumenentals of BioRestorative Therapies

BioRestorative Therapies Net Debt component correlations

About BioRestorative Therapies Financial Statements

Also Currently Popular

Additional Tools for BioRestorative Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY